Previous 10 | Next 10 |
Teleflex Incorporated (TFX) Q3 2019 Earnings Conference Call October 31, 2019 8:00 AM ET Company Participants Jake Elguicze – Treasurer and Vice President-Investor Relations Liam Kelly – President and Chief Executive Officer Thomas Powell – Executive Vice Pre...
The following slide deck was published by Teleflex Incorporated in conjunction with their 2019 Q3 earnings Read more ...
Third Quarter Revenues from Continuing Operations of $648.3 million, up 6.3% versus the Prior Year Period; up 8.0% on a Constant Currency Basis Third Quarter GAAP Diluted EPS from Continuing Operations of $4.85, up 300.8% Versus the Prior Year Period Third Quarter Adjusted Di...
Teleflex ( TFX ) is a medical device manufacturer. Its revenue has been growing at a CAGR of 5.78% and EBITDA has been growing at a CAGR of 6.88% in the last ten years. However, the stock is richly valued compared to its competitors. The company has a few growth drivers in place. Investors are...
WAYNE, Pa., Oct. 17, 2019 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) announced today that financial results for the third quarter 2019 will be released before market open on Thursday, October 31, 2019. An investor conference call will be held at 8:00 a.m. (ET) on Thursday, ...
Source Introduction Traditionally, most of my analysis on Seeking Alpha has focused on how to avoid losses and how to profit from the price cycles of classic cyclical stocks. There is another group of stocks, however, whose stock prices and earnings fluctuate far less than the classic cy...
In a release issued under the same headline earlier today by Teleflex Incorporated (NYSE: TFX) please note that in the seventh paragraph of the release, the recall notice link was incorrect and the correct link is https://p.widencdn.net/ainca1/EIF-000364---Supplier-Galemed-Babi-Plus-Recall...
WAYNE, Pa., Oct. 07, 2019 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), announced a recall June 14 th , 2019 of certain lots of the GaleMed (third party manufacturer) Babi.Plus ® 12.5 cm H 2 O Pressure Relief Manifold. Teleflex receives the product from the manufacturer Gal...
WAYNE, Pa., Sept. 25, 2019 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the tenth anniversary of its industry-leading GuideLiner ® Catheter. Released in November 2009, the GuideLiner ® Catheter r...
WAYNE, Pa., Sept. 16, 2019 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) today announced the publication of an article showcasing the effectiveness and overall benefits of the minimally invasive UroLift ® System treatment for patients with benign prostatic hyperplasia (BP...
News, Short Squeeze, Breakout and More Instantly...
WAYNE, Pa., July 31, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Ringer™ Perfusion Balloon Catheter (PBC), the only commercially available Perc...
WAYNE, Pa., July 29, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it was awarded two group purchasing agreements with Premier, Inc. Effective July 1, 2024, the Premier National Hemostasis Products and SURPASS® ...
WAYNE, Pa., July 24, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the establishment of the Teleflex Center for Antimicrobial Protection (TCAP) as a strategic branch of its Vascular Access business unit led by Chuck ...